Dr. Alina Shevchenko, MD

Dr. Shevchenko practices at Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Shevchenko's NPI, 1245723550, was assigned on June 11, 2018. Dr. Shevchenko graduated from Temple University School of Medicine in 2018. Dr. Shevchenko holds Pennsylvania license MD477049.

Dr. Shevchenko's primary practice is Fox Chase Cancer Center, at 333 Cottman Avenue, Philadelphia, PA 19111.

Dr. Shevchenko's primary practice is Fox Chase Cancer Center in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Shevchenko is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Shevchenko to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shevchenko practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Shevchenko's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Shevchenko is licensed in Pennsylvania.

CMS data shows 2,018 Medicare services from Dr. Shevchenko across 10 procedure codes in 2024, for 584 Medicare patients. Medicare paid $78,175 for them.

CMS counts 584 Medicare patients who saw Dr. Shevchenko in 2024. The largest group is 65 to 74, with 300 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shevchenko's median patient age at 72, with 62% women.

In 2024, Dr. Shevchenko wrote 903 Medicare Part D claims for 307 patients. 66% of them were for generic drugs. CMS names the drug for 810 of them, across 15 drugs with 11 or more claims each, at $1,137,869 in total drug cost. In 2023, CMS named 444 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Shevchenko for performance year 2024, reported as part of a group. Dr. Shevchenko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 584 procedures of skin biopsy by Dr. Shevchenko, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Shevchenko, published from 2017 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Biopsy and Skin. Dr. Shevchenko has published most often in Itch (Phila). Dr. Shevchenko's most frequent co-authors are Sylvia Hsu, MD, Rodrigo Hernando Valdes-Rodriguez, MD and Gil Yosipovitch, MD.

CMS Open Payments shows 45 general payments to Dr. Shevchenko from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 59% of the total. Janssen Pharmaceuticals, Inc paid the most, $516.

Dr. Shevchenko graduated from Temple University School of Medicine in 2018.